Industry Reports
Recipharm awarded for growth in France
Recipharm, a leading CDMO , has received recognition for its commitment to its French operations. The award “le Prix d’Excellence 2017 - Spécial Sciences...
Research Insight
Mount Sinai Researchers Identify Novel Therapeutic Targets for Metastatic Melanoma, Path for New Drugs
Mount Sinai researchers have identified novel therapeutic targets for metastatic melanoma, according to a study published in Molecular Cell. The study...
News
NBE-Therapeutics Appoints Dr. Nicole Onetto to Its Board of Directors
NBE Therapeutics AG, a biopharmaceutical company developing next-generation ADCs carrying highly potent, immune-stimulatory anthracycline toxins, announces the appointment of Dr. Nicole Onetto to its...
Press Releases
Recipharm equips a further three facilities for US serialisation
Recipharm, a leading contract development and manufacturing organisation (CDMO) has equipped three more of its facilities with serialisation capabilities in line with the US...
News
Landmark Celebration of UBM India’s 11th edition of CPhI & P-MEC India gets underway today
UBM India, India's leading B2B exhibition organizer saw the launch of the grand 11th edition of the signature event, CPhI & P-MEC India 2017,...
News
Essentra will showcase its innovative pharmaceutical packaging, labels, serialisation and patient adherence solutions at CPhI India
Essentra, a global leader in healthcare packaging, will showcase its innovative pharmaceutical packaging, labels, serialisation and patient adherence solutions at CPhI India, 27-29th November...
Press Releases
Orchard Therapeutics Announces Extension of its Collaboration with Manchester University to Include Sanfilippo Syndrome Type B
Orchard Therapeutics Limited (“Orchard”), a clinical-stage biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read